(Total Views: 321)
Posted On: 01/11/2018 3:25:55 PM
Post# of 11802
Even though this was a little while ago 12/13/17, I thought it was interesting and wanted to share. IMO.
https://globenewswire.com/news-release/2017/1...-2022.html
from the article.
Companies mentioned in this report include Abbott Labs, Apple, Ascensia Diabetes Care Holdings, Cellnovo Group, Debiotech, Echo Therapeutics, Glooko, Insulet, Johnson & Johnson, Labstyle Innovations, Medella Health, Medtronic, Nemaura Medical, Novo Nordisk, Onduo, Pharma Tech Solutions, Roche, Sanofi, Tandem Diabetes Care, Unilife and Ypsomed, among others.
GLTA!
https://globenewswire.com/news-release/2017/1...-2022.html
from the article.
Companies mentioned in this report include Abbott Labs, Apple, Ascensia Diabetes Care Holdings, Cellnovo Group, Debiotech, Echo Therapeutics, Glooko, Insulet, Johnson & Johnson, Labstyle Innovations, Medella Health, Medtronic, Nemaura Medical, Novo Nordisk, Onduo, Pharma Tech Solutions, Roche, Sanofi, Tandem Diabetes Care, Unilife and Ypsomed, among others.
GLTA!
(0)
(0)
Scroll down for more posts ▼